Healthcare / Medical Care FacilitiesBSE
$37.60
-1.70 (-4.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $18.6M · quality 62.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
26/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$281M
P/E
N/A
•EV/EBITDA
71.1x
↑ROE
72.8%
↑Gross Margin
74.7%
↑Debt/Equity
-5.63
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.5%
FCF CAGR
+6.8%
FCF margin
5.5%
FCF / Net income
-1.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $346.7M · net income $-13.7M · FCF $19.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $346.7M | $346.7M | $380.5M | $386.1M | $313.1M |
| Net Income | $-13.7M | $-13.7M | $-4.3M | $8.9M | $39.8M |
| EBITDA | $5.1M | $5.1M | $20.2M | $32.1M | $59.2M |
| EPS | -1.84 | -1.84 | -0.57 | 1.19 | 5.32 |
| Gross Margin | 74.7% | 74.7% | 75.3% | 75.0% | 69.3% |
| Operating Margin | -4.3% | -4.3% | 1.5% | 4.5% | 14.4% |
| Net Margin | -4.0% | -4.0% | -1.1% | 2.3% | 12.7% |
| Balance Sheet | |||||
| Debt/Equity | -5.63 | -5.63 | -34.86 | 87.39 | -13.68 |
| Current Ratio | 0.67 | 0.67 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $19.0M | $19.0M | $-1.2M | $18.6M | $15.6M |
| Returns | |||||
| ROE | 72.8% | 72.8% | 130.5% | 732.3% | -511.8% |
| Valuation | |||||
| P/E | — | — | — | 16.56 | 4.44 |
| EV/EBITDA | 71.06 | 71.06 | 18.35 | 7.12 | 4.23 |
| P/B | — | — | — | 121.06 | — |
| Growth & Yield | |||||
| Revenue Growth | -8.9% | -8.9% | -1.5% | 23.3% | — |
| EPS Growth | -222.8% | -222.8% | -147.9% | -77.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.57 → -1.84
Residual
+12.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.